Atrás
Rango del Día
$16.10
$16.44
Rango de 52 Semanas
$13.46
$31.04
Volumen
735,783
Promedio 50D / 200D
$22.12
/
$22.79
Cierre Anterior
$16.33
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (627 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -8.4 | 0.4 |
| P/B | 0.5 | 2.9 |
| ROE % | -5.4 | 3.7 |
| Net Margin % | -18.8 | 3.9 |
| Rev Growth 5Y % | -24.5 | 10.0 |
| D/E | 0.0 | 0.2 |
Precio Objetivo de Analistas
Hold
$36.00
+120.3%
EPS Futuro
-$1.41
Ingresos Est.
350 M
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2028 |
-$1.44
-$1.46 – -$1.42
|
430 M | 1 |
| FY2027 |
-$1.48
-$1.71 – -$1.26
|
390 M | 2 |
| FY2026 |
-$1.41
-$1.51 – -$1.30
|
350 M | 2 |
Puntos Clave
Revenue declined -24.49% annually over 5 years
Debt/Equity of 0.00 — conservative balance sheet
Negative free cash flow of -124.21M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 38.32%
Capital efficient — spends only 7.00% of revenue on capex
Crecimiento
Revenue Growth (5Y)
-24.49%
Revenue (1Y)13.83%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
-5.39%
ROIC-6.14%
Net Margin-18.75%
Op. Margin-28.23%
Seguridad
Debt / Equity
0.00
Current Ratio6.48
Interest Coverage-1214.61
Valoración
P/E Ratio
-8.43
P/B Ratio0.46
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 13.83% | Revenue Growth (3Y) | 5.63% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -24.49% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 322.67M | Net Income (TTM) | -60.51M |
| ROE | -5.39% | ROA | -4.99% |
| Gross Margin | 40.56% | Operating Margin | -28.23% |
| Net Margin | -18.75% | Free Cash Flow (TTM) | -124.21M |
| ROIC | -6.14% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.00 | Current Ratio | 6.48 |
| Interest Coverage | -1214.61 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -8.43 | P/B Ratio | 0.46 |
| P/S Ratio | 1.58 | PEG Ratio | -0.34 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 510.31M | Enterprise Value | 460.59M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 322.67M | 283.47M | 289.21M | 618.97M | 992.58M |
| Net Income | -60.51M | -42.71M | -167.83M | 143.40M | 507.36M |
| EPS (Diluted) | -1.97 | -1.41 | -5.63 | 4.63 | 16.26 |
| Gross Profit | 130.88M | 107.22M | 104.46M | 366.90M | 777.05M |
| Operating Income | -91.10M | -73.92M | -195.53M | 178.53M | 675.95M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1.21B | 1.22B | 1.24B | 1.39B | 1.28B |
| Total Liabilities | 106.81M | 90.81M | 102.04M | 116.18M | 112.84M |
| Shareholders' Equity | 1.11B | 1.13B | 1.14B | 1.27B | 1.16B |
| Total Debt | 476,000.0 | 8.47M | 15.25M | 38.94M | 21.28M |
| Cash & Equivalents | 50.19M | 55.14M | 97.47M | 79.51M | 164.89M |
| Current Assets | 550.49M | 353.57M | 507.85M | 627.87M | 611.96M |
| Current Liabilities | 84.97M | 72.90M | 73.02M | 88.11M | 105.31M |